Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.
Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page
- Check2 days agoChange DetectedAdded a Locations section listing study sites in Barcelona, Canary Islands, Murcia, and Navarre and updated to revision v3.3.3; the separate location subsections and the HHS Vulnerability Disclosure entry were removed.SummaryDifference0.5%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2, a minor metadata-level update with no visible changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check31 days agoChange DetectedPublications section updated with a clarifying note that publications are provided voluntarily by the person entering study information and relate to the study results; the document revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check38 days agoChange DetectedRemoved the notice about a lapse in government funding and the NIH Clinical Center operating status from the page.SummaryDifference0.3%
- Check52 days agoChange DetectedNo additions or deletions to the page's core content were detected, and the study details appear unchanged between the two screenshots.SummaryDifference0.4%
- Check81 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%
Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.